Drexler et al. found that IL-1R- and caspase-1-deficient mice were partially protected against skin cancer induced by 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) treatments (114). Here, IL1R1 is linked to skin cancer.